Reprint

Lung Ultrasound: A Leading Diagnostic Tool

Edited by
September 2023
326 pages
  • ISBN978-3-0365-8741-7 (Hardback)
  • ISBN978-3-0365-8740-0 (PDF)

This book is a reprint of the Special Issue Lung Ultrasound: A Leading Diagnostic Tool that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Since the time I met Dr. Soldati, we have never stopped investigating LUS (lung ultrasound) vertical artifacts and the latter have slowly revealed their physical nature. Acoustic traps exist in pathological conditions that trap part of the energy of US pulses and gradually return it over time. Ultrasound scanners interpret what comes next as echoes of more distant structures, and this simple fact explains the nature of vertical signs: they are the visible representation of acoustic energy emitted from isolated, non-aerated spaces located beneath the pleura. In short, a vertical sign is a bit like the signature of an acoustic trap that generates it, similar to footprints left by animals in the woods—we just have to learn to recognize these signs. When we began our collaboration, lung ultrasound was a tool with limited application by pulmonary physicians. Today, the application of LUS is widespread, and medical and nonmedical doctors are collaborating to provide scientific answers to many questions that still arise when observing the aforementioned phenomenon. We must never get tired of reiterating the importance of collaboration between medical and nonmedical doctors in the development of new diagnostic devices.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
B-line; lung ultrasonography; LUS; interstitial lung disease; systemic sclerosis; pulmonary fibrosis; oedema; lung ultrasound; hand-held ultrasound device; lung disease; COVID-19 (Coronavirus Disease 2019); lung ultrasound; B-line score; extravascular lung water; fluid management; intensive care; randomised controlled trial; lung ultrasound; implementation science; point-of-care ultrasound; lung ultrasound; B-lines; vertical artifacts; pulmonary artifacts; physical models; lung ultrasound; neonates; newborns; COVID-19; SARS-CoV-2; lung ultrasound; COVID-19; SARS-CoV-2; pneumonia; point of care; interstitial syndrome; chest ultrasound; lung ultrasonography LUS; B lines; vertical artifacts; sonomorphology of artifacts; cardiac edema; pulmonary fibrosis; interstitial pneumonia; lung ultrasound; cardiogenic pulmonary edema; B-line; vertical artifact; spatial compound imaging; focal point; lung ultrasound; cystic fibrosis; computed tomography comparison; CT; congenital; pediatric; echo; ultrasound; cardiac; COVID-19; clinical review; lung ultrasound imaging; diagnosis; lung; respiratory medicine; sonography; ultrasound; lung ultrasound; high resolution computed tomography; SARS-CoV-19; interstitial pneumonia; ARDS; lung ultrasonography; respiratory distress syndrome; preterm infants; SARS-CoV-2 infection; COVID-19; children; lung ultrasound; chest ultrasound; medical thoracoscopy; pleural effusion; pleural malignancy; lung ultrasonography; B-lines; simulation; COMSOL; finite element method; point-of-care ultrasound; patient self-care; telementoring; informatics; community out-reach (Min. 5–Max. 8); lung ultrasound; B-lines; dry weight; intradialytic hypotension; fluid overload; post-COVID-syndrome; lung ultrasound; COVID-19; LUS; lung ultrasound; b-lines; vertical artifacts; pulmonary artifacts; physical models; lung ultrasound; pneumonia; pulmonary infection; n/a